Ankit Madan, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients
Cancer Chemotherapy and Pharmacology
Volume 78, Issue 3, pp 509–515
Date: 09 2016
link.springer.com.ezproxy3.lhl.uab.edu/article/10.1007/s00280-016-3088-5

High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes
PLoS one
10,issue number 9
Date: 01 2017
go.galegroup.com.ezproxy3.lhl.uab.edu/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchRes